Mirum Pharmaceuticals International B.V.
ItalyAll drugs from this manufacturer
-
It is used to treat cholestatic pruritus in patients with Alagille syndrome (over 2 months of age) and to treat progressive familial intrahepatic cholestasis (PFIC) in patients over 3 months of age.
Dosage form: solution, oral
Active substance Dosage maralixibat chloride - ATC: A05AX04